Contact
searchSearch
HMP Global
Login

Suicide Topic Center

a man holds his head in his hands
News
Cohort Study Finds Increased Suicide Risk in Survivors of Traumatic Injury
01/21/2026
Maria Mantas
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after...
01/21/2026
Psych Congress Network
US FDA building
News
FDA Requests Removal of Suicide Risk Warnings From GLP-1 RA Labels
01/14/2026
Maria Mantas
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug...
01/14/2026
Psych Congress Network
A clinician and a patient
News
Cognitive Behavioral Therapy With Narrative Assessment Linked to Lower Suicide Attempt Risk
11/24/2025
Maria Mantas
A recent meta-analysis found that integrating a narrative component into cognitive behavioral therapy (CBT) substantially improved suicide prevention outcomes.
A recent meta-analysis found that integrating a narrative component into cognitive behavioral therapy (CBT) substantially improved suicide prevention outcomes.
A recent meta-analysis found...
11/24/2025
Psych Congress Network
Increase in Suicidality Associated With FDA Black Box Warning Implementation
News
Increase in Suicidality Associated With FDA Black Box Warning Implementation
10/11/2024
Evi Arthur
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on...
10/11/2024
Psych Congress Network
A depressed teen rides the bus and looks at a smartphone in their hand
News
Adolescents May Not Reliably Signal Self-Harm Risk on PHQ in Primary Care Screenings
05/13/2024
Jolynn Tumolo
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were...
05/13/2024
Psych Congress Network
FDA
Quiz
What were the FDA's preliminary findings after investigating GLP-1 RAs?
04/25/2024
Do you remember this FDA update?
Do you remember this FDA update?
Do you remember this FDA update?
04/25/2024
Psych Congress Network
$52.5 Million Awarded in Federal Grants for Veteran Suicide Prevention
News
$52.5 Million Awarded in Federal Grants for Veteran Suicide Prevention
02/21/2024
Hannah Musick
In a recent press release, the US Department of Veterans Affairs announced it would award $52.5 million in grants to community-based organizations that provide or coordinate suicide prevention services for veterans and their families.
In a recent press release, the US Department of Veterans Affairs announced it would award $52.5 million in grants to community-based organizations that provide or coordinate suicide prevention services for veterans and their families.
In a recent press release, the...
02/21/2024
Psych Congress Network
FDA
News
FDA Preliminary Evaluation Finds No Clear Link Between GLP-1 Drugs and Suicidal Thoughts, Cautions on Small Risk
01/26/2024
Meagan Thistle
The FDA's preliminary evaluation of GLP-1 RAs found no evidence that the medications cause suicidal drugs or actions but cautions that a small risk cannot yet be ruled out.
The FDA's preliminary evaluation of GLP-1 RAs found no evidence that the medications cause suicidal drugs or actions but cautions that a small risk cannot yet be ruled out.
The FDA's preliminary evaluation...
01/26/2024
Psych Congress Network
Illustration two profiles with brains
News
Hospitalization Following Suicide Attempt May Benefit Some, but Individualized Approach Needed
10/25/2023
Brionna Mendoza
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may...
10/25/2023
Psych Congress Network
Teens with Headaches Report Increased Rates of Bullying, Suicidality
News
Teens With Headaches Report Increased Rates of Bullying, Suicidality
08/14/2023
Jolynn Tumolo
Adolescents who have been bullied or who have considered or attempted suicide may be more likely to experience headaches than their peers, according to study results published in Neurology.
Adolescents who have been bullied or who have considered or attempted suicide may be more likely to experience headaches than their peers, according to study results published in Neurology.
Adolescents who have been...
08/14/2023
Neurology
From Neurology
News
Rumination Linked With Suicidal Thoughts in Teens With Major Depressive Disorder
04/17/2023
Jolynn Tumolo
Elevated cognitive rumination was associated with suicidal ideation in adolescents with depression, according to findings published in the Journal of Affective Disorders
Elevated cognitive rumination was associated with suicidal ideation in adolescents with depression, according to findings published in the Journal of Affective Disorders
Elevated cognitive rumination...
04/17/2023
Psych Congress Network

News Articles

a man holds his head in his hands
News
Cohort Study Finds Increased Suicide Risk in Survivors of Traumatic Injury
01/21/2026
Maria Mantas
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after...
01/21/2026
Psych Congress Network
US FDA building
News
FDA Requests Removal of Suicide Risk Warnings From GLP-1 RA Labels
01/14/2026
Maria Mantas
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug...
01/14/2026
Psych Congress Network
A clinician and a patient
News
Cognitive Behavioral Therapy With Narrative Assessment Linked to Lower Suicide Attempt Risk
11/24/2025
Maria Mantas
A recent meta-analysis found that integrating a narrative component into cognitive behavioral therapy (CBT) substantially improved suicide prevention outcomes.
A recent meta-analysis found that integrating a narrative component into cognitive behavioral therapy (CBT) substantially improved suicide prevention outcomes.
A recent meta-analysis found...
11/24/2025
Psych Congress Network
Increase in Suicidality Associated With FDA Black Box Warning Implementation
News
Increase in Suicidality Associated With FDA Black Box Warning Implementation
10/11/2024
Evi Arthur
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on...
10/11/2024
Psych Congress Network
A depressed teen rides the bus and looks at a smartphone in their hand
News
Adolescents May Not Reliably Signal Self-Harm Risk on PHQ in Primary Care Screenings
05/13/2024
Jolynn Tumolo
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were...
05/13/2024
Psych Congress Network
$52.5 Million Awarded in Federal Grants for Veteran Suicide Prevention
News
$52.5 Million Awarded in Federal Grants for Veteran Suicide Prevention
02/21/2024
Hannah Musick
In a recent press release, the US Department of Veterans Affairs announced it would award $52.5 million in grants to community-based organizations that provide or coordinate suicide prevention services for veterans and their families.
In a recent press release, the US Department of Veterans Affairs announced it would award $52.5 million in grants to community-based organizations that provide or coordinate suicide prevention services for veterans and their families.
In a recent press release, the...
02/21/2024
Psych Congress Network
FDA
News
FDA Preliminary Evaluation Finds No Clear Link Between GLP-1 Drugs and Suicidal Thoughts, Cautions on Small Risk
01/26/2024
Meagan Thistle
The FDA's preliminary evaluation of GLP-1 RAs found no evidence that the medications cause suicidal drugs or actions but cautions that a small risk cannot yet be ruled out.
The FDA's preliminary evaluation of GLP-1 RAs found no evidence that the medications cause suicidal drugs or actions but cautions that a small risk cannot yet be ruled out.
The FDA's preliminary evaluation...
01/26/2024
Psych Congress Network
Illustration two profiles with brains
News
Hospitalization Following Suicide Attempt May Benefit Some, but Individualized Approach Needed
10/25/2023
Brionna Mendoza
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may...
10/25/2023
Psych Congress Network
Teens with Headaches Report Increased Rates of Bullying, Suicidality
News
Teens With Headaches Report Increased Rates of Bullying, Suicidality
08/14/2023
Jolynn Tumolo
Adolescents who have been bullied or who have considered or attempted suicide may be more likely to experience headaches than their peers, according to study results published in Neurology.
Adolescents who have been bullied or who have considered or attempted suicide may be more likely to experience headaches than their peers, according to study results published in Neurology.
Adolescents who have been...
08/14/2023
Neurology
News
Rumination Linked With Suicidal Thoughts in Teens With Major Depressive Disorder
04/17/2023
Jolynn Tumolo
Elevated cognitive rumination was associated with suicidal ideation in adolescents with depression, according to findings published in the Journal of Affective Disorders
Elevated cognitive rumination was associated with suicidal ideation in adolescents with depression, according to findings published in the Journal of Affective Disorders
Elevated cognitive rumination...
04/17/2023
Psych Congress Network
An orange prescription container with generic pills spilling out in front of it
News
Antidepressant Use Not Linked to Worse Traumatic Brain Injury Outcomes
02/03/2026
Brionna Mendoza
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study...
02/03/2026
Psych Congress Network
A frustrated man works on a laptop
News
Frequent Generative AI Use Linked to Increased Depressive Symptoms
01/23/2026
Maria Mantas
Daily or more frequent generative AI use was associated with higher depressive symptom scores on the PHQ-9 compared with nonuse in a large US survey.
Daily or more frequent generative AI use was associated with higher depressive symptom scores on the PHQ-9 compared with nonuse in a large US survey.
Daily or more frequent...
01/23/2026
Psych Congress Network
a man holds his head in his hands
News
Cohort Study Finds Increased Suicide Risk in Survivors of Traumatic Injury
01/21/2026
Maria Mantas
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after...
01/21/2026
Psych Congress Network
A man looks out a window
News
Adjunctive Vagus Nerve Stimulation Shows Durable Benefit in Treatment-Resistant Depression
01/20/2026
Maria Mantas
A long-term extension study found that adjunctive vagus nerve stimulation (VNS) had a durable benefit in patients with treatment-resistant major depression over 24 months.
A long-term extension study found that adjunctive vagus nerve stimulation (VNS) had a durable benefit in patients with treatment-resistant major depression over 24 months.
A long-term extension study...
01/20/2026
Psych Congress Network
a depressed teen adolescent holds head in hands crying upset sad major depression
News
Omega-3 Supplements Show No Benefit for Pediatric Major Depression in RCT
01/20/2026
Brionna Mendoza
A multicenter randomized clinical trial found that adding omega-3 fatty acid supplements to psychotherapy did not improve outcomes in children and adolescents with moderate-to-severe major depression.
A multicenter randomized clinical trial found that adding omega-3 fatty acid supplements to psychotherapy did not improve outcomes in children and adolescents with moderate-to-severe major depression.
A multicenter randomized...
01/20/2026
Psych Congress Network
brain
News
Several Noninvasive Brain Stimulation Modalities Show Benefit for Treatment-Resistant Schizophrenia
01/19/2026
Maria Mantas
A large network meta-analysis found specific noninvasive brain stimulation (NIBS) modalities improved symptoms in treatment-resistant schizophrenia (TRS).
A large network meta-analysis found specific noninvasive brain stimulation (NIBS) modalities improved symptoms in treatment-resistant schizophrenia (TRS).
A large network meta-analysis...
01/19/2026
Psych Congress Network
US FDA building
News
FDA Requests Removal of Suicide Risk Warnings From GLP-1 RA Labels
01/14/2026
Maria Mantas
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug...
01/14/2026
Psych Congress Network
illustration of a brain
News
Meta-Analysis Confirms Processing Speed as Core Cognitive Deficit in Schizophrenia
01/12/2026
Maria Mantas
Processing speed remains one of the most severely impaired cognitive domains in people with schizophrenia, according to a large systematic review and meta-analysis published in JAMA Psychiatry.
Processing speed remains one of the most severely impaired cognitive domains in people with schizophrenia, according to a large systematic review and meta-analysis published in JAMA Psychiatry.
Processing speed remains one of...
01/12/2026
Psych Congress Network
FDA building
News
FDA Approves At-Home Neuromodulation Therapy Device for Major Depression
01/12/2026
Maria Mantas
The US Food and Drug Administration has approved Proliv™Rx, a novel at-home neuromodulation therapy as adjunctive treatment for adults with major depressive disorder (MDD).
The US Food and Drug Administration has approved Proliv™Rx, a novel at-home neuromodulation therapy as adjunctive treatment for adults with major depressive disorder (MDD).
The US Food and Drug...
01/12/2026
Psych Congress Network
woman on a hill
News
Delay Discounting Fails to Predict Antidepressant Relapse in MDD
01/09/2026
Maria Mantas
A new multi-site study suggests that while delay discounting is elevated in patients with remitted MDD, it neither changes after antidepressant medication discontinuation nor predicts subsequent depressive relapse.
A new multi-site study suggests that while delay discounting is elevated in patients with remitted MDD, it neither changes after antidepressant medication discontinuation nor predicts subsequent depressive relapse.
A new multi-site study suggests...
01/09/2026
Psych Congress Network

Videos

Dr Jody Russon
Videos
Better Treatment Through Understanding Suicide in LGBTQIA+ Community
04/06/2023
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Jody Russon, PhD, discusses the theories that can help clinicians better understand the concern of suicide in the LGBTQIA+ community.
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Jody Russon, PhD, discusses the theories that can help clinicians better understand the concern of suicide in the LGBTQIA+ community.
In this clip from Psych Congress...
04/06/2023
Psych Congress Network
balfour and winsky
Videos
New 988 Mental Health Crisis Response Hotline Highlights Need for Standardization
06/27/2022
In the conclusion of this 3-part video, Margaret (Margie) E. Balfour, MD, PhD, and Sergeant Jason Winsky, BA, discuss tips for family members and clinicians during a mental health crisis and the upcoming 988 hotline launching July, 2022.
In the conclusion of this 3-part video, Margaret (Margie) E. Balfour, MD, PhD, and Sergeant Jason Winsky, BA, discuss tips for family members and clinicians during a mental health crisis and the upcoming 988 hotline launching July, 2022.
In the conclusion of this 3-part...
06/27/2022
Psych Congress Network
Reclaiming Nurses Week
Videos
Reclaiming Nurses Week Part 5: An Open Letter to Our Nurses
05/11/2022
Watch our final video of the series, Reclaiming Nurses Week Part 5: An Open Letter to Our Nurses.
Watch our final video of the series, Reclaiming Nurses Week Part 5: An Open Letter to Our Nurses.
Watch our final video of the...
05/11/2022
Psych Congress Network
Reclaiming Nurses Week
Videos
Reclaiming Nurses Week Part 4: Nurses Mental Health
05/10/2022
Reclaiming Nurses Week Part 4: Nurses Mental Health. Hear the stories of stigma surrounding asking for help.
Reclaiming Nurses Week Part 4: Nurses Mental Health. Hear the stories of stigma surrounding asking for help.
Reclaiming Nurses Week Part 4:...
05/10/2022
Psych Congress Network
Reclaiming Nurses Week
Videos
Reclaiming Nurses Week Part 3: The Solution
05/09/2022
In this installment of Reclaiming Nurses Week, we address The Solution. Nurses share the changes that need to be made and the resources that are currently available.
In this installment of Reclaiming Nurses Week, we address The Solution. Nurses share the changes that need to be made and the resources that are currently available.
In this installment of...
05/09/2022
Psych Congress Network
Reclaiming Nurses Week
Videos
Reclaiming Nurses Week Part 2: The Cause
05/08/2022
In Part 2 of this video series, Reclaiming Nurses Week, we hear about The Cause as nurses share the reasons behind their mental health struggles.
In Part 2 of this video series, Reclaiming Nurses Week, we hear about The Cause as nurses share the reasons behind their mental health struggles.
In Part 2 of this video series,...
05/08/2022
Psych Congress Network
Reclaiming Nurses Week
Videos
Reclaiming Nurses Week Part 1: The Problem
05/07/2022
Reclaiming Nurses Week Part 1: The Problem. Stories from our nurses identifying the impact of burnout on their mental health.
Reclaiming Nurses Week Part 1: The Problem. Stories from our nurses identifying the impact of burnout on their mental health.
Reclaiming Nurses Week Part 1:...
05/07/2022
Psych Congress Network
Dr King
Videos
The Acceptability and Next Steps With the CASSY Suicide Screening Tool
01/24/2022
In the conclusion of this video series, Cheryl King, PhD, professor in the Departments of Psychiatry and Psychology and Director of the Youth Depression and Suicide Prevention Program at the University of Michigan, Ann Arbor, discusses the...
In the conclusion of this video series, Cheryl King, PhD, professor in the Departments of Psychiatry and Psychology and Director of the Youth Depression and Suicide Prevention Program at the University of Michigan, Ann Arbor, discusses the...
In the conclusion of this video...
01/24/2022
Psych Congress Network
Dr King
Videos
The Acceptability and Next Steps With the CASSY Suicide Screening Tool
01/24/2022
Cheryl King, PhD, discusses the acceptability to both parents and youth for this screening tool, next steps in implementation, as well as the stigma of suicidal ideation in youth.
Cheryl King, PhD, discusses the acceptability to both parents and youth for this screening tool, next steps in implementation, as well as the stigma of suicidal ideation in youth.
Cheryl King, PhD, discusses the...
01/24/2022
Psych Congress Network
Dr King
Videos
Developing the CASSY Suicide Screening Tool
01/18/2022
Cheryl King, PhD, discusses the studies that determined the validity and accuracy of the CASSY suicide screening tool.
Cheryl King, PhD, discusses the studies that determined the validity and accuracy of the CASSY suicide screening tool.
Cheryl King, PhD, discusses the...
01/18/2022
Psych Congress Network
Greg Mattingly, MD
Videos
VMAT-2 Inhibitor Differences and Dosing in Tardive Dyskinesia
01/09/2026
Greg Mattingly, MD
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg...
01/09/2026
Psych Congress Network
Greg Mattingly, MD
Videos
VMAT-2 Inhibitor Differences and Dosing in Tardive Dyskinesia
01/09/2026
Greg Mattingly, MD
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg...
01/09/2026
Psych Congress Network
Steven Chan, MD, MBA
Videos
Digital Mental Health Trends: Policy, Telehealth, and Generative AI
01/07/2026
Steven Chan, MD, MBA
In this video, Psych Congress Steering Committee Member Steven Chan, MD, MBA, FAPA, FAMIA, offers an overview of the most pressing topics in digital mental health.
In this video, Psych Congress Steering Committee Member Steven Chan, MD, MBA, FAPA, FAMIA, offers an overview of the most pressing topics in digital mental health.
In this video, Psych Congress...
01/07/2026
Psych Congress Network
Michael Asbach, DMsc, PA-C
Videos
Differentiating Bipolar II Disorder From Other Psychiatric Conditions
12/08/2025
Michael Asbach, DMSc, PA-C
In this video, Michael Asbach, DMSc, PA-C, walks clinicians through some key clinical considerations for navigating diagnostic ambiguity when assessing patients for bipolar II disorder.
In this video, Michael Asbach, DMSc, PA-C, walks clinicians through some key clinical considerations for navigating diagnostic ambiguity when assessing patients for bipolar II disorder.
In this video, Michael Asbach,...
12/08/2025
Psych Congress Network
Desiree Matthews, PMHNP-BC
Videos
Using Digital Tools to Reduce Clinician Burnout
12/03/2025
Desiree Matthews, PHMNP-BC
In this video filmed at Psych Congress 2025, Steering Committee member Desiree Matthews, PMHNP-BC, discusses the ways in which digital tools can be leveraged to reduce provider burnout.
In this video filmed at Psych Congress 2025, Steering Committee member Desiree Matthews, PMHNP-BC, discusses the ways in which digital tools can be leveraged to reduce provider burnout.
In this video filmed at Psych...
12/03/2025
Psych Congress Network
Craig Chepke, MD, DFAPA
Videos
Comparing Real-World Data on LAIs and Oral Antipsychotics
12/01/2025
Craig Chepke, MD, DFAPA
In this video, Craig Chepke, MD, DFAPA, discusses real-world findings that clinicians should be aware of when considering the use of oral or LAI antipsychotics for schizophrenia treatment.
In this video, Craig Chepke, MD, DFAPA, discusses real-world findings that clinicians should be aware of when considering the use of oral or LAI antipsychotics for schizophrenia treatment.
In this video, Craig Chepke, MD,...
12/01/2025
Psych Congress Network
Timothy Wilens, MD
Videos
Leveraging Digital Therapeutics for ADHD Management
11/14/2025
Timothy Wilens, MD
In this video filmed on-site at Psych Congress 2025, faculty member Timothy Wilens, MD, discusses the role that digital therapeutics may play in the management of attention-deficit/hyperactivity disorder (ADHD).
In this video filmed on-site at Psych Congress 2025, faculty member Timothy Wilens, MD, discusses the role that digital therapeutics may play in the management of attention-deficit/hyperactivity disorder (ADHD).
In this video filmed on-site at...
11/14/2025
Psych Congress Network
Jonathan Meyer, MD
Videos
Updated Approaches to Clozapine Monitoring Post-REMS
11/11/2025
Jonathan Meyer, MD
Filmed at the 2025 Psych Congress, Jonathan Meyer, MD, offers an updated approach for clinicians navigating clozapine monitoring following the end of Risk Evaluation and Mitigation Strategy (REMS) program.
Filmed at the 2025 Psych Congress, Jonathan Meyer, MD, offers an updated approach for clinicians navigating clozapine monitoring following the end of Risk Evaluation and Mitigation Strategy (REMS) program.
Filmed at the 2025 Psych...
11/11/2025
Psych Congress Network
Edward Kaftarian, MD
Videos
Avoiding Legal Gray Areas in Cross-State Telepsychiatry
11/04/2025
Edward Kaftarian, MD
In this video, Psych Congress Steering Committee Member Edward Kaftarian, MD, dives into potential legal gray areas that clinicians may encounter when engaging in cross-state telepsychiatry.
In this video, Psych Congress Steering Committee Member Edward Kaftarian, MD, dives into potential legal gray areas that clinicians may encounter when engaging in cross-state telepsychiatry.
In this video, Psych Congress...
11/04/2025
Psych Congress Network
Timothy Wilens, MD
Videos
Navigating Psychiatric Comorbidities in ADHD
10/17/2025
Timothy Wilens, MD
In this insightful discussion, Psych Congress Faculty Member Timothy Wilens, MD, dissects the challenges clinicians may face when diagnosing and treating common psychiatric comorbidities in individuals with ADHD.
In this insightful discussion, Psych Congress Faculty Member Timothy Wilens, MD, dissects the challenges clinicians may face when diagnosing and treating common psychiatric comorbidities in individuals with ADHD.
In this insightful discussion,...
10/17/2025
Psych Congress Network

Blogs

Michael Myers
Blog
National Physician Suicide Awareness Day 2021: With Gratitude to the Feists
10/07/2021
Michael Myers
Michael Myers, MD, reflects on National Physician Suicide Awareness Day.
Michael Myers, MD, reflects on National Physician Suicide Awareness Day.
Michael Myers, MD, reflects on...
10/07/2021
Psych Congress Network
Michael_Myers
Blog
It Is Never Too Late
06/04/2021
Michael Myers
BLOG: I have kept all the files of my patients who have died by suicide [including] ones under my care when they died & those who were no longer my patients when they took their lives.
BLOG: I have kept all the files of my patients who have died by suicide [including] ones under my care when they died & those who were no longer my patients when they took their lives.
BLOG: I have kept all the files...
06/04/2021
Psych Congress Network
myers
Blog
Remembering Dr. Lorna Breen on National Physician Suicide Awareness Day
10/05/2020
Michael Myers
BLOG: National Physician Suicide Awareness Day is a day of reflection and pause, a day to remember physicians who have taken their own lives. It is also a day of hope and collaboration, people coming together with ideas and energy to make a...
BLOG: National Physician Suicide Awareness Day is a day of reflection and pause, a day to remember physicians who have taken their own lives. It is also a day of hope and collaboration, people coming together with ideas and energy to make a...
BLOG: National Physician Suicide...
10/05/2020
Psych Congress Network
Michael Myers
Blog
National Physician Suicide Awareness Day: We Refuse to Forget
10/16/2019
Michael Myers
BLOG: September 17, 2019 was the second annual National Physician Suicide Awareness Day, a day to commemorate colleagues lost to suicide and raise awareness about the issue.
BLOG: September 17, 2019 was the second annual National Physician Suicide Awareness Day, a day to commemorate colleagues lost to suicide and raise awareness about the issue.
BLOG: September 17, 2019 was the...
10/16/2019
Psych Congress Network
Michael Myers
Blog
Reflections on National Physician Suicide Awareness Day
10/04/2018
Michael Myers
BLOG: September 17, 2018 was designated as the first National Physician Suicide Awareness Day in this country. All of us in the mental health community can be grateful for the pioneering and hard work of Dr. Loice Swisher, who took...
BLOG: September 17, 2018 was designated as the first National Physician Suicide Awareness Day in this country. All of us in the mental health community can be grateful for the pioneering and hard work of Dr. Loice Swisher, who took...
BLOG: September 17, 2018...
10/04/2018
Psych Congress Network
Blog
Transform our shock into action
06/12/2018
A few short days ago, the very tragic deaths of fashion designer Kate Spade and international chef Anthony Bourdain stunned us. Our national suicide rate is skyrocketing, and now exceeds the annual number of deaths due to car accidents.
A few short days ago, the very tragic deaths of fashion designer Kate Spade and international chef Anthony Bourdain stunned us. Our national suicide rate is skyrocketing, and now exceeds the annual number of deaths due to car accidents.
A few short days ago, the very...
06/12/2018
Psych Congress Network
Blog
Let’s Lead the Conversation About Suicide
06/08/2018
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: As mental health professionals, we have the opportunities to be leaders within our communities to help address this problem. Let’s lead by example to make talking about mental health and suicide as normal as talking about the game last...
BLOG: As mental health professionals, we have the opportunities to be leaders within our communities to help address this problem. Let’s lead by example to make talking about mental health and suicide as normal as talking about the game last...
BLOG: As mental health...
06/08/2018
Psych Congress Network
Blog
What if we treat drug overdoses like suicide attempts?
09/21/2017
All of us who work in behavioral health know that the opioid epidemic is possibly the greatest challenge in healthcare today. However, the usual response to opioid overdoses—immediate treatment with Narcan and release—has proven...
All of us who work in behavioral health know that the opioid epidemic is possibly the greatest challenge in healthcare today. However, the usual response to opioid overdoses—immediate treatment with Narcan and release—has proven...
All of us who work in behavioral...
09/21/2017
Psych Congress Network
Blog
What is our clinical responsibility for suicide?
06/19/2017
If you're like me, you may be wondering whether the case of a young woman who was found guilty on Friday of involuntary manslaughter relates to our clinical work. She encouraged her boyfriend to follow through on his suicide attempt by...
If you're like me, you may be wondering whether the case of a young woman who was found guilty on Friday of involuntary manslaughter relates to our clinical work. She encouraged her boyfriend to follow through on his suicide attempt by...
If you're like me, you may...
06/19/2017
Psych Congress Network
Blog
Too high a price to pay?
12/20/2012
In a June 2011 story, “New perspectives on suicide prevention,” I wrote about the three elements of the  “interpersonal theory of suicide,” advanced by Thomas Joiner PhD of the University of Florida. As I reported...
In a June 2011 story, “New perspectives on suicide prevention,” I wrote about the three elements of the  “interpersonal theory of suicide,” advanced by Thomas Joiner PhD of the University of Florida. As I reported...
In a June 2011 story, “New...
12/20/2012
Psych Congress Network
marc agronin md
Faculty Insights
Alzheimer Disease Prevention: Part 2
07/29/2024
Marc E. Agronin, MD
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network
Rakesh Amin, MD.
Blog
Treating Schizophrenia: The Importance of Early Identification and Intervention
06/13/2023
Rakesh Amin, MD
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the...
06/13/2023
Psych Congress Network
Marc Agronin, MD.
Blog
Alzheimer Disease Prevention
08/30/2022
Marc E. Agronin, MD
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section...
08/30/2022
Psych Congress Network
Ed Jones, PhD
Blog
How Our Clinicians Can Help Fix the US Health Care System
07/28/2022
Ed Jones, PhD
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the...
07/28/2022
Psych Congress Network
Ed Jones, PhD
Perspective
The Universal Behavior Model: A Comprehensive Approach to Integrated Care
07/21/2022
Ed Jones, PhD
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this...
07/21/2022
Psych Congress Network
Chan_Khan_Digital Mental Health
Blog
Who will use it? How to Get Digital Mental Health Apps Into the Hands of Patients
04/27/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan...
04/27/2022
Psychiatry & Behavioral Health
Chan_Khan_Digital Mental Health
Blog
How to Navigate Quality Issues With Mental Health Apps
04/21/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan...
04/21/2022
Psychiatry & Behavioral Health
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Blog
How New NPs Can Find Mentors
03/04/2022
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains...
03/04/2022
Psych Congress Network
Julie Bailey
Blog
How to Be a Safe Space for Someone
02/08/2022
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey,...
02/08/2022
Psych Congress Network
major depressive disorder
Blog
The Best and Worst Changes Brought On By the Pandemic
01/31/2022
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy...
01/31/2022
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use